Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectogesic for chronic venous leg ulcers
ACTRN12616000520437Phase 2Recruiting
- Sponsor
- The Prince Charles Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stasis ulcer comparing Rectogesic ointment with Placebo ointment (2 arms). Primary endpoint: Linear healing rate by planimetry. Started Dec 2016; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on ACTRN12616000520437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000520437.